Sugar may be the cause of suffering from painful gastrointestinal symptoms: Third Annual National Sucrose Intolerance Awareness Week April 5-11, 2021
VERO BEACH, Fla., March 30, 2021 /PRNewswire/ -- QOL Medical, LLC today announced their theme for the 3rd annual National Sucrose Intolerance Awareness Week, from April 5-11, 2021. This year's theme, "Why am I so bloated?" is designed to address one of the most common and painful symptoms of this often misdiagnosed gastrointestinal condition.
This week has been established to raise awareness about the unmet needs of people suffering from symptoms due to an inability to digest sucrose (table sugar). Sucrose Intolerance due to Congenital Sucrase-Isomaltase Deficiency (CSID) is caused by genetic variants that result in diminished or absent digestive activity of sucrase-isomaltase, an enzyme in the small intestine. The reduction or absence of this enzyme activity makes it difficult to properly digest sucrose (table sugar) and starch found in many foods.
"Our goal this year is to raise awareness using one of the most common symptoms of Sucrose Intolerance, which is bloating. Many patients suffer for years with debilitating symptoms before getting properly diagnosed, as so many of the symptoms are similar to other more common gut health conditions," said Anthony D'Elia, Vice President of Marketing for QOL Medical, LLC.
Sucrose Intolerance caused by CSID is a chronic medical condition, affecting infants, teens, and adults. The symptoms typically occur after eating or drinking foods high in sugar, like apple juice, ice cream, cake, and a variety of fruits and vegetables. Symptoms include:
- Abdominal pain
- Gas
- Bloating
- Chronic diarrhea
- Nausea
In infants, complications from these symptoms may also cause colic-like symptoms, dehydration, malnutrition, and failure to thrive. Learn more at http://www.sucroseintoleranceawareness.org. There is no cure for Sucrose Intolerance (CSID), but there are treatment options available to help minimize symptoms.
About QOL Medical, LLC
QOL Medical is a specialty biopharmaceutical company dedicated to improving clinical outcomes and the overall quality of life for patients with rare diseases. QOL Medical is a patient-centric company founded in 2003 to focus on the acquisition and commercialization of orphan and gastrointestinal products in underserved markets. Learn more at www.qolmed.com.
Media Contact:
QOL Medical, LLC
Tiffany Carter
Phone: 818-720-8557
Email: [email protected]
Corporate Contact:
QOL Medical, LLC
3405 Ocean Drive
Vero Beach, FL 32963
Phone: 866-469-3773
Fax: 772-365-3375
Email: [email protected]
SOURCE QOL Medical, LLC
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article